美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Lombard Medical, Inc.

0.2230

+0.0000

成交量：- -

成交額：- -

市值：623.31萬

市盈率：-0.14

高：0.2230

開：0.2230

低：0.2230

收：0.2230

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Lombard Medical, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.lombardmedical.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Lombard Medical, Inc.是一家獲得開曼群島豁免的有限責任公司並於2014年1月16號註冊成立。這家公司是一家醫療技術公司，專門從事開發、製造和銷售解決組動脈瘤修復需要的血管內支架移植。公司的主要產品Aorfix是唯一的主動脈修復瘤。或者叫AAA，對副主動脈瘤的治療角度高達90度。AAA是一個像氣球一樣的物品置於腹腔內，如果不進行治療，可能會導致主動脈破裂。大多數副主動脈瘤的破裂是致命的。根據iData研究公司，AAs是導致美國65歲及以上男性死亡的第十三大原因。副主動脈瘤目前主要通過侵入性和創傷性手術進行治療，或者通過微創主動脈腔內修復。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/EVAR/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EVAR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EVAR\",,,,,undefined,":{"symbol":"EVAR","market":"US","secType":"STK","nameCN":"Lombard Medical, Inc.","latestPrice":0.223,"timestamp":1510174800000,"preClose":0.223,"halted":4,"volume":0,"delay":0,"floatShares":12670000,"shares":27951000,"eps":-1.54,"marketStatus":"退市","change":0,"latestTime":"11-08 16:00:00 EST","open":0.223,"high":0.223,"low":0.223,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.54,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1398398400000,"exchange":"NASDAQ","adjPreClose":0.223,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EVAR\",,,,,undefined,":{"symbol":"EVAR","floatShares":12670000,"roa":"--","roe":"--","lyrEps":0,"shares":27951000,"dividePrice":0,"high":0.223,"amplitude":0,"preClose":0.223,"low":0.223,"week52Low":0.22,"pbRate":"0.45","week52High":0.92,"institutionHeld":0,"latestPrice":0.223,"eps":-1.54,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.54,"open":0.223},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.lombardmedical.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.049},{"period":"1year","weight":0.0936},{"period":"ytd","weight":-0.0605}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Lombard Medical, Inc.是一家獲得開曼群島豁免的有限責任公司並於2014年1月16號註冊成立。這家公司是一家醫療技術公司，專門從事開發、製造和銷售解決組動脈瘤修復需要的血管內支架移植。公司的主要產品Aorfix是唯一的主動脈修復瘤。或者叫AAA，對副主動脈瘤的治療角度高達90度。AAA是一個像氣球一樣的物品置於腹腔內，如果不進行治療，可能會導致主動脈破裂。大多數副主動脈瘤的破裂是致命的。根據iData研究公司，AAs是導致美國65歲及以上男性死亡的第十三大原因。副主動脈瘤目前主要通過侵入性和創傷性手術進行治療，或者通過微創主動脈腔內修復。","exchange":"NASDAQ","name":"Lombard Medical, Inc.","nameEN":"Lombard Medical"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"EVAR\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EVAR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-04-18","symbol":"EVAR","fiscalQuarterEnding":"2016/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1492488000000,"reportTimeType":"","actualEps":-0.25},{"market":"US","date":"2016-10-27","symbol":"EVAR","fiscalQuarterEnding":"2016/09","expectedEps":-0.27,"name":null,"time":"","type":"earning","dateTimestamp":1477540800000,"reportTimeType":"","actualEps":-0.37},{"market":"US","date":"2016-08-22","symbol":"EVAR","fiscalQuarterEnding":"2016/06","expectedEps":-0.39,"name":null,"time":"盤後","type":"earning","dateTimestamp":1471838400000,"reportTimeType":"post","actualEps":-0.42},{"market":"US","date":"2016-05-11","symbol":"EVAR","fiscalQuarterEnding":"2016/03","expectedEps":-0.4,"name":null,"time":"盤後","type":"earning","dateTimestamp":1462939200000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2016-02-22","symbol":"EVAR","fiscalQuarterEnding":"2015/12","expectedEps":-0.42,"name":null,"time":"盤前","type":"earning","dateTimestamp":1456117200000,"reportTimeType":"pre","actualEps":-0.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EVAR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EVAR\",market:\"US\",delay:false,,,undefined,":{}}}